Medical Pharmacology: Immunopharmacology
Practice Questions
Click on the correct answer.
Agent acts directly at site 6 to diminish tissue injury: (see figure)
- tacrolimus
- cyclosporine (Sandimmune, Neoral)
- prednisone (Deltasone)
- dactinomycin (Cosmegen)
- methotrexate
Act(s) at site 2, reducing proliferation (see figure)
- prednisone (Deltasone)
- tacrolimus
- azathioprine (Imuran)
- A & B
- A, B & C
Inhibit(s) at differentiation/synthesis step (see figure):
- prednisone (Deltasone)
- cyclophosphamide (Cytoxan)
- dactinomycin (Cosmegen)
- methotrexate
- azathioprine (Imuran)
Acts at three sites: antigen recognition site, proliferation step, and differentiation/synthesis steps: (see figure)
- prednisone (Deltasone)
- antilymphocyte globulin & monoclonal anti-T cell antibodies
- RHo(D) immune globulin
- cyclophosphamide (Cytoxan)
- all of the above
Anti-profilerative site of action:
- antilymphocyte globulin & monoclonal anti-T cell antibodies
- dactinomycin (Cosmegen)
- methotrexate
- azathioprine (Imuran)
- all the above
Acts at antigen recognition site: (see figure)
- prednisone (Deltasone)
- tacrolimus
- azathioprine (Imuran)
- RHo(D) immune globulin
- cyclophosphamide (Cytoxan)
If you wish to return to the Table of Contents
in ENGLISH, press the RETURN button above. |
Otherwise, if the text is NOT displayed in
English and you are ready to leave this page,
Press here
to return to the Table of Contents
|